Table 1 Differences between heterotaxy and non-heterotaxy patients
Heterotaxy (%) | Non-heterotaxy (%) | P value | |
|---|---|---|---|
N | 39 | 71 | |
Observation period (mo) | 90.8 ± 93.9 | 107.7 ± 56.1 | 0.310 |
Male | 25 (64.1) | 35 (49.3) | 0.163 |
Major associated anomaly | |||
Pulmonary atresia | 19 (48.7) | 23 (32.4) | 0.344 |
Anomalous pulmonary venous return | 14 (35.9) | 6 (8.5) | 0.079 |
Age of 1st palliation (mo) | 3.0 ± 3.1 | 2.9 ± 6.7 | 0.907 |
1st palliation | 0.546 | ||
BT shunt | 25 (64.1) | 46 (64.8) | |
PAB | 2 (5.1) | 10 (14.1) | |
BCPS | 12 (30.8) | 15 (21.1) | |
Mortality | 16 (41.0) | 8 (11.3) | 0.001 |
Median age of death (range) (mo) | 4.4 (1.2-221.1) | 9.4 (3.1-35.7) | 0.427 |
Median time to death after palliation (range) (mo) | 2.5 (0.6-62.2) | 5.1 (1.7-32.3) | 0.838 |
Causes of death | |||
Infection | 6 (37.5) | 3 (37.5) | |
Sudden death | 5 (31.3) | 3 (37.5) | |
Arrhythmia | 2 (12.5) | 0 | |
Pulmonary venous obstruction | 2 (12.5) | 1 (12.5) | |
Heart failure | 1 (6.3) | 1 (12.5) | |
Time of mortality | 0.722 | ||
Before BCPS | 13 (81.3) | 6 (75.0) | |
After BCPS | 3 (18.7) | 2 (25.0) | |